Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study

Moore MP, Kinne DW: Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol 66: 2–6, 1997 Fisher B: Laboratory and clinical research in breast cancer — a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res 40: 3863–3874, 1980 Forrest AP, Stewart HJ, Roberts MM, et al: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196: 371–378, 1982 Ahlgren J, Holmberg L, Bergh J, et al: Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol 28:97–102, 2002 Sato K, Tamaki K, Takeuchi H, et al: Management of the axilla in breast cancer: a comparative study between sentinel lymph node biopsy and four-node sampling procedure. Jpn J Clin Oncol 31: 318–321, 2001 Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335–340, 1993 Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391–398, 1994 Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276: 1818–1822, 1996 Al-Hilaly M, Willsher PC, Robertson JFR, et al: Audit of a conservative management policy of the axilla in elderly patients with operable breast cancer. Eur J Surg Oncol 23: 339–340, 1997 Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337: 956–962, 1997 Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337: 949–955, 1997 Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353: 1641–1648, 1999 Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96: 115–121, 2004 Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival -a Bayesian meta-analysis. Ann Surg Oncol 6: 109–116, 1999 Early Breast Cancer Trialists’ Collaborative Group: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087–2106, 2005 Silverstein MJ, Lagios MD, Recht A, et al: Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 201: 586–597, 2005 Schwartz GF, Giuliano AE, Veronesi U, et al: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer 94: 2542–2551, 2002 Pendas S, Dauway E, Giuliano R, et al: Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7: 15–20, 2000 Klauber-DeMore N, Tan LK, Liberman L, et al: Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7: 636–642, 2000 Cox CE, Nguyen K, Gray RJ, et al: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67: 513–521, 2001 Intra M, Zurrida S, Maffini F, et al: Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 10: 1160–1165, 2003 Degnim AC, Griffith KA, Sabel MS, etal: Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 98: 2307–2315, 2003 Cserni G, Gregori D, Merletti F, et al: Non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer: metaanalysis of 25 studies. Br J Surg 91: 1245–1252, 2004 Schrenk P, Konstantiniuk P, Wolfl S, et al: Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 92: 707–713, 2005 Houvenaeghel G, Nos C, Mignotte H, et al: Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement—Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 24: 1814–1822, 2006 Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10: 1140–1151, 2003 Lambert LA, Ayers GD, Hwang RF, et al: Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13: 310–320, 2006 Smidt ML, Kuster DM, van der Wilt GJ, et al: Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 12: 1066–1072, 2005 Kocsis L, Svébis M, Boross G, et al: Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 70: 1019–1024, 2004 Degnim AC, Reynolds C, Pantvaidya G, et al: Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190: 543–550, 2005 Cserni G: Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node positive breast cancer patients. Am J Surg (in press) Cserni G, Amendoeira I, Apostolikas N, et al: Pathological workup of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39: 1654–1667, 2003 Cserni G, Amendoeira I, Apostolikas N, et al: Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57: 695–701, 2004 Cserni G, Bianchi S, Boecker W, et al: Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 103: 358–367, 2005 Cserni G, Bianchi S, Vezzosi V, et al: The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma. J Clin Pathol 59: 518–522, 2006 Perry N, Broeders M, de Wolf C, et al (Eds): European Guidelines for Breast Screening and Diagnosis. European Communities, Luxemburg, 2006 Sobin LH andWittekind C (Eds): UICC TNM Classification of Malignant Tumors, 6th edition. John Wiley and Sons, Inc., New-York, 2002 Ellis IO, Pinder SE, Bobrow L, et al: Pathology reporting of breast disease, http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58-low-resolution.pdf. (Last assessed: 11 November 2006) Tavassoli FA, Devilee P (Eds): World Health Organization: Tumors of the Breast and Female Genital Organs, 4th edition, IARC Press, Lyon, 2003 Greene FL, Page DL, Fleming ID, et al (Eds): AJCC Cancer Staging Handbook — TNM Classification of Malignant Tumors, 6th edition. Springer Verlag, New York, 2002 Hermanek P, Hutter RVP, Sobin LH, et al: Classification of isolated tumor cells and micrometastasis. Cancer 86: 2668–2673, 1999 Cserni G, Sapino A, Decker T: Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 15: 347–354, 2006 Miller WG: OpenStat. http://www.statpages.org/miller/openstat/OpenStathtm (Last assessed: 15 August 2006) Cserni G, Burzykowski T, Vinh-Hung V, et al: Axillary sentinel node and tumor-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol 34: 519–524, 2004 Woodward WA, Vinh-Hung V, Ueno NT, et al: Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24: 2910–2916, 2006 Cady B: New era in breast cancer. Impact of screening on disease presentation. Surg Oncol Clin N Am 6: 195–202, 1997 McMasters KM, Chao C, Wong SL, et al: Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer 95: 15–20, 2002 Holloway C: Surgery for ductal carcinoma in situ. Curr Probl Cancer 24: 141–162, 2000 Lagios MD, Silverstein MJ: Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 8: 275–277, 2001 Intra M, Veronesi P, Mazzarol G, et al: Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138: 309–313, 2003 Trisal V, Qian D, Wagman LD: Axillary recurrence in DCIS: is axillary lymphadenectomy warranted? Am Surg 70: 876–880, 2004 Leidenius M, Salmenkivi K, von Smitten K, et al: Tumor-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 94: 380–384, 2006 Cserni G, Boross G, Maráz R, et al: Sentinel lymph node biopsy for in situ carcinoma of the breast. Experience at the Bacs-Kiskun County Hospital and review of the literature [In Hungarian]. Magy Seb 59: 164–172, 2006 Török K, Péley G, Mátrai Z, et al: The role of sentinel lymph node biopsy for staging patients with ductal carcinoma in situ of the breast. [In Hungarian] Magy Seb 59: 173–178, 2006 Damiani S, Ludvikova M, Tomasic G, et al: Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study. Virchows Arch 434: 227–234, 1999 Moran CJ, Kell MR, Kerin MJ: The role of sentinel lymph node biopsy in ductal carcinoma in situ. EJSO 31: 1105–1111, 2005 Silverstein MJ, Rosser RJ, Gierson ED, et al: Axillary lymph node dissection for intraductal breast carcinoma — is it indicated? Cancer 59: 1819–1824, 1987 Arisio R, Sapino A, Cassoni P, et al: What modifies the relation between tumor size and lymph node metastases in Tl breast carcinomas? J Clin Pathol 53: 846–850, 2000 Delia Rovere GQ, Bonomi R, Ashley S, et al: Axillary staging in women with small invasive breast tumors. EJSO 32: 733–737, 2006 Diaz LK, Wiley EL, Venta LA: Are malignant cells displaced by large-gauge needle core biopsy of the breast? Am J Roentgenol 173: 1303–1313, 1999 Diaz NM, Mayes JR, Vrcel V: Breast epithelial cells in dermal angiolymphatic spaces: a manifestation of benign mechanical transport. Hum Pathol 36: 310–313, 2005 Nagi C, Bleiweiss I, Jaffer S: Epithelial displacement in breast lesions: a papillary phenomenon. Arch Pathol Lab Med 129: 1465–1469, 2005 Bleiweiss IJ, Nagi CS, Jaffer S: Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24: 2013–2018, 2006 Bleiweiss IJ: Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles. Lancet Oncol 7: 686–692, 2006 Viale G, Zurrida S, Maiorano E, et al: Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103: 492–500, 2005 Vinh-Hung V, Verschraegen C, Promish DI, et al: Ratios of involved nodes in early breast cancer. Breast Cancer Res 6: R680–688, 2004 Calhoun KE, Hansen NM, Turner RR, et al: Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190: 588–591, 2005 van Rijk MC, Peterse JL, Nieweg OE, et al: Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer 107: 467–471, 2006